Ethical Considerations for the Clinical Oncologist in an Era of Oncology Drug Shortages

Author(s)
Jagsi, Reshma
Spence, Rebecca
Rathmell, W. Kimryn
Bradbury, Angela
Peppercorn, Jeffrey
Grubbs, Stephen
Moy, Beverly
Keywords
Medical Ethics

Full record
Show full item record
URI
http://hdl.handle.net/20.500.12424/264938
Online Access
https://dx.doi.org/10.1634/theoncologist.2013-0301
Abstract
The authors review the history, causes, and regulatory context of oncology drug shortages in the U.S., as well as the literature, policy analyses, and other relevant sources to provide oncologists with ethical guidance when faced with oncology drug shortages. Practical recommendations are discussed.
Date
2014-02
Type
Text
Identifier
oai:pubmedcentral.nih.gov:3926786
/pmc/articles/PMC3926786/
/pubmed/24449096
http://dx.doi.org/10.1634/theoncologist.2013-0301
Copyright/License
©AlphaMed Press
Collections